A plain language summary of the BASIS study looking at people living with severe hemophilia A or B with inhibitors and being treated with marstacimab.
Saved in:
| Title: | A plain language summary of the BASIS study looking at people living with severe hemophilia A or B with inhibitors and being treated with marstacimab. |
|---|---|
| Authors: | Matino D; Thrombosis and Atherosclerosis Research Institute, McMaster University, and Department of Medicine, McMaster University, Hamilton, ON, Canada., Acharya SS; Northwell Health, New Hyde Park, NY and Cohen Children's Medical Center, Queens, NY, USA., Taylor CT; Pfizer Inc, Collegeville, PA, USA., Sun P; Pfizer Inc, Cambridge, MA, USA., Agathon D; Pfizer Inc, Paris, France., Raje S; Pfizer Inc, Collegeville, PA, USA., Gould T; Pfizer Inc, New York, NY, USA., Palladino A; Pfizer Inc, Collegeville, PA, USA., Mahlangu J; Department of Molecular Medicine and Haematology, Faculty of Health Sciences, University of the Witwatersrand, National Health Laboratory Service, Johannesburg, South Africa. |
| Source: | Therapeutic advances in hematology [Ther Adv Hematol] 2026 Jun 14; Vol. 17, pp. 20406207261442896. Date of Electronic Publication: 2026 Jun 14 (Print Publication: 2026). |
| Publication Type: | Editorial |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 101549589 Publication Model: eCollection Cited Medium: Print ISSN: 2040-6207 (Print) Linking ISSN: 20406207 NLM ISO Abbreviation: Ther Adv Hematol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2040-6207 |
|---|---|
| DOI: | 10.1177/20406207261442896 |
